IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial
Renata Moll‐Bernardes(D’Or Institute for Research and Education), Emiliano Medei(Universidade Federal do Rio de Janeiro), Mauro Jorge Cabral‐Castro(Universidade Federal do Rio de Janeiro), Fábio Augusto de Luca(Hospital São Paulo), Karla G. D. Giusti, Guilherme D. A. S. Arruda(Universidade Municipal de São Caetano do Sul), Olga Ferreira de Souza(D’Or Institute for Research and Education), Ariane Vieira Scarlatelli Macedo(Santa Casa Hospital), Marisol D. M. Kotsugai(Hospital São Paulo), Renato D. Lópes(Duke University), Mayara Fraga Santos(D’Or Institute for Research and Education), Rafael Domiciano(Hospital São Paulo), Fernando A. Bozza(D’Or Institute for Research and Education), Pedro M. Pimentel‐Coelho(Universidade Federal do Rio de Janeiro), Denílson Campos de Albuquerque(Universidade do Estado do Rio de Janeiro), Ronir Raggio Luiz(Universidade Federal do Rio de Janeiro), Vitor Alves Loures(Hospital São Paulo), André Feldman(D’Or Institute for Research and Education), Thyago Antônio Biagioni Furquim, Luciana C. R. Maia(Universidade Federal do Rio de Janeiro), Thiago Ceccatto de Paula(Hospital São Paulo), Narendra Vera(Universidade Federal do Rio de Janeiro), Nathália M. de Oliveira, Andréa Silvestre de Sousa(D’Or Institute for Research and Education)
Cited by 36
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744